PATENT CLAIM ANALYSIS

Application Number: 15753461
Application Type: Utility
Filing Date: 2018-02
Publication Date: 2018-08
Patent Classification: ["514", "04400A"]

Abstract:
Methods and compounds useful to treat diseases and conditions are provided. Methods of administering one or more microRNA-inhibitor compounds or one or more microRNA-enhancing compounds to cells, tissues, and/or subjects as a treatment for a disease or condition are provided.

Claim (Index 54):
The method of  claim 53 , wherein determining the amount of activity of one or both of miRNA-873-5p and miRNA-518d-5p in the cell comprises comparing GNMT enzyme activity in the contacted cell to GNMT activity in a control cell not contacted with the candidate miRNA-modulator compound, wherein an increase in GNMT enzyme activity in the contacted cell versus the control cell identifies the candidate miRNA-modulator as an miRNA-inhibitor compound and wherein a decrease in GNMT enzyme activity in the contacted cell versus the control cell identifies the candidate miRNA-modulator as an miRNA-enhancer compound.

Metadata:
- Claim Count in Document: 2.0
- Percentile: 88.0
- Lexical Diversity: 1.51724
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['13566138', '15845573', '13453553', '14009276', '12615969']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8014188367998794
- 35 USC 102 Novelty (BERT): 0.5182936680309465
- Combined Prediction Score: 0.7731063199229862
- Mean Citation Score: 295.9812639999999
- Max Citation Score: 304.17758
- Similarity Product: 211.3009247923469

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test